TCMBANKIN000192 |
hosenkosides C |
|
|
979.3 |
|
TCMBANKIN000249 |
Lawsone |
2-Oxylato-1,4-naphthoquinone; A840637; lawsone; 3,4-bis(oxidanylidene)naphthalen-1-olate; 2-hydroxy-1,4-naphtoquinone; 3,4-dioxo-1-naphthalenolate |
C10H6O3 |
174.15 |
C1=CC=C2C(=C1)C(=CC(=O)C2=O)[O-] |
TCMBANKIN000517 |
cis-5,8,11,14,17-Eicosapentaenoic acid methyl ester |
methyl (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate; 17266_FLUKA; E2012_SIGMA; 5,8,11,14,17-Eicosapentaenoic acid, methyl ester, (all-Z)-; (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoic acid methyl ester; Methyl all-cis-5,8,11,14,17-eicosapentaenoate |
C21H32O2 |
316.48 |
CCC=CCC=CCC=CCC=CCC=CCCCC(=O)OC |
TCMBANKIN002132 |
methyl (E)-hexadec-2-enoate |
Methyl (2E)-2-hexadecenoate; 2-Hexadecenoic acid, methyl ester, (E)-; (E)-hexadec-2-enoic acid methyl ester; 29960-49-4; 2825-81-2; Methyl trans-2-hexadecenoate |
C17H32O2 |
268.4 g/mol |
CCCCCCCCCCCCCC=CC(=O)OC |
TCMBANKIN002148 |
METHYL PALMITOLEATE |
P9667_SIGMA; Methyl (Z)-hexadec-9-enoate; InChI=1/C17H32O2/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17(18)19-2/h8-9H,3-7,10-16H2,1-2H3/b9-8; 76176_FLUKA; methyl (9Z)-hexadec-9-enoate; 9-Hexadecenoic acid, methyl ester, (Z)-; EINECS 214-303-2; 1120-25-8; Palmitoleic acid methyl ester; Methyl cis-9-hexadecenoate; (Z)-hexadec-9-enoic acid methyl ester; 9-hexadecenoic acid, methyl ester, (9Z)-; AI3-36450 |
C17H32O2 |
268.43 |
CCCCCCC=CCCCCCCCC(=O)OC |
TCMBANKIN004423 |
methyl (Z)-hexadec-7-enoate |
(Z)-hexadec-7-enoic acid methyl ester; 16651_FLUKA; Fame 16:1n-9; cis-7-Hexadecenoic acid methyl ester solution |
|
268.49 |
|
TCMBANKIN005257 |
2,2-Dimethyloctane |
InChI=1/C10H22/c1-5-6-7-8-9-10(2,3)4/h5-9H2,1-4H; 15869-87-1; Octane, 2,2-dimethyl- |
C10H22 |
142.28 |
CCCCCCC(C)(C)C |
TCMBANKIN007317 |
hosenkosides E |
|
|
817.14 |
|
TCMBANKIN009041 |
Ethyl oleate |
9-Octadecenoic acid (Z)-, ethyl ester; 9-Octadecenoic acid, (Z)-, ethyl ester; NSC 229428; 9-Octadecenoic acid, ethyl ester, (E)-; EINECS 203-889-5; Ethyl cis-9-octadecenoate; 9-OCTADECENOIC ACID ETHYL ESTER (Z); FEMA No. 2450; EINECS 228-082-5; octadec-9-enoic acid ethyl ester; Oleic acid, ethyl ester; 9-Octadecenoic acid (9Z)-, ethyl ester; Ethyl elaidate; ST5410316; ethyl (E)-octadec-9-enoate; (E)-octadec-9-enoic acid ethyl ester; ethyl oleate; 111-62-6; AI3-00657; 6114-18-7; Ethyl oleate (natural); Ethyl (9E)-9-octadecenoate; Elaidic acid ethyl ester; NSC229428; ethyl octadec-9-enoate; Ethyl 9-octadecenoate, (Z)-; (E)-9-Octadecenoic acid ethyl ester; E8377_SIGMA; 9-Octadecenoic acid, ethyl ester; Oleic acid, ethyl ester (6CI,8CI) |
C20H38O2 |
310.51 |
CCCCCCCCC=CCCCCCCCC(=O)OCC |
TCMBANKIN009288 |
pariphyllin |
|
|
|
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)C)O)O)O)OC9C(C(C(O9)CO)O)O)O)C)C)C)OC1 |
TCMBANKIN010417 |
einulsin |
|
|
|
|
TCMBANKIN011947 |
balsaminone A |
balsaminone B_qt |
C21H12O5 |
344.3 g/mol |
COC1=C(C2=CC=CC=C2C3=C1C4=C(O3)C(=O)C5=CC=CC=C5C4=O)O |
TCMBANKIN013111 |
Methyl 9-oxononanoate |
1931-63-1; Nonanoic acid, 9-oxo-, methyl ester; Methyl 8-formyloctanoate; AI3-25458; Methyl azelaaldehydate; NSC53771; Azelaaldehydic acid, methyl ester; 9-ketopelargonic acid methyl ester; Methyl azelaaldehydrate; 9-Oxononanoic acid methyl ester |
C10H18O3 |
186.25 |
COC(=O)CCCCCCCC=O |
TCMBANKIN013634 |
hosenkosides B |
|
|
979.3 |
|
TCMBANKIN014484 |
laxogenin |
|
C27H42O4 |
430.62 |
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC(=O)C6C5(CCC(C6)O)C)C)C)OC1 |
TCMBANKIN015081 |
parinaric acid |
parinaricacid |
C18H28O2 |
276.4 g/mol |
CCC=CC=CC=CC=CCCCCCCCC(=O)O |
TCMBANKIN015278 |
Methyl arachidonate |
A9298_SIGMA; Arachidonic acid methyl ester; Methyl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate; EINECS 219-900-1; 5,8,11,14-Eicosatetraenoic acid, methyl ester, (all-Z)-; (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid methyl ester; 2566-89-4 |
C21H34O2 |
318.49 |
CCCCCC=CCC=CCC=CCC=CCCCC(=O)OC |
TCMBANKIN017882 |
hosenkosides D |
|
|
817.14 |
|
TCMBANKIN018493 |
(2E,4E,6E,8Z)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraen-1-ol |
|
C20H30O |
286.45 |
|
TCMBANKIN018555 |
2-Methoxy-obtusifolin |
InChI=1/C17H14O5/c1-8-7-10-13(17(22-3)16(8)21-2)15(20)12-9(14(10)19)5-4-6-11(12)18/h4-7,18H,1-3H3; AKOS030561357; 8-hydroxy-1,2-dimethoxy-3-methylanthracene-9,10-dione; 8-hydroxy-1,2-dimethoxy-3-methyl-9,10-anthraquinone; SCHEMBL3257870; 8-hydroxy-1,2-dimethoxy-3-methyl-anthracene-9,10-dione; AK593054; 82868-99-3; AC1NSY5J; LPMLREFNXDLTSN-UHFFFAOYSA-; 2-methoxy-obtusifolin; DTXSID80415754; 9,10-Anthracenedione, 8-hydroxy-1,2-dimethoxy-3-methyl-; CTK3D5745; 1,2-Dimethoxy-3-methyl-8-hydroxy-9,10-anthraquinone |
C17H14O5 |
298.29 g/mol |
CC1=CC2=C(C(=C1OC)OC)C(=O)C3=C(C2=O)C=CC=C3O |
TCMBANKIN021864 |
balsaminasterol |
|
|
|
|
TCMBANKIN022668 |
hosenkosides A |
|
|
979.3 |
|
TCMBANKIN026744 |
hosenkosides D_qt |
hosenkosides A_qt |
|
492.82 |
|
TCMBANKIN028279 |
glycerol-1-(9-octadecenoate) |
|
C21H40O4 |
356.5 g/mol |
CCCCCCCCC=CCCCCCCCC(=O)OCC(CO)O |
TCMBANKIN028709 |
hosenkosides E_qt |
hosenkosides B_qt |
|
492.82 |
|
TCMBANKIN030408 |
balsaminone B |
|
C27H22O10 |
506.5 g/mol |
COC1=C(C2=CC=CC=C2C3=C1C4=C(O3)C(=O)C5=CC=CC=C5C4=O)OC6C(C(C(C(O6)CO)O)O)O |
TCMBANKIN031034 |
methyl (Z)-icos-11-enoate |
(Z)-icos-11-enoic acid methyl ester; 11-Eicosenoic acid, methyl ester, (Z)-; E6885_SIGMA; 17263_FLUKA; Methyl cis-11-eicosenoate; cis-11-Eicosenoic acid, methyl ester; cis-11-Eicosenoic acid methyl ester |
C21H40O2 |
324.5 g/mol |
CCCCCCCCC=CCCCCCCCCCC(=O)OC |
TCMBANKIN033049 |
hosenkosides C_qt |
|
|
492.82 |
|
TCMBANKIN035925 |
(1R,2S,2'S,4aR,4bR,6aR,7R,8S,10aR,10bR,12aS)-7-(hydroxymethyl)-2'-[(2S)-1-hydroxypropan-2-yl]-4a,4b,7,10a-tetramethylspiro[3,4,5,6,6a,8,9,10,10b,11,12,12a-dodecahydro-1H-chrysene-2,5'-oxane]-1,8-diol |
(1R,2S,2'S,4aR,4bR,6aR,7R,8S,10aR,10bR,12aS)-2'-[(1S)-2-hydroxy-1-methyl-ethyl]-4a,4b,7,10a-tetramethyl-7-methylol-spiro[3,4,5,6,6a,8,9,10,10b,11,12,12a-dodecahydro-1H-chrysene-2,5'-tetrahydropyran]-1,8-diol; (1R,2S,2'S,4aR,4bR,6aR,7R,8S,10aR,10bR,12aS)-7-(hydroxymethyl)-2'-[(2S)-1-hydroxypropan-2-yl]-4a,4b,7,10a-tetramethyl-spiro[3,4,5,6,6a,8,9,10,10b,11,12,12a-dodecahydro-1H-chrysene-2,5'-oxane]-1,8-diol; (1R,2S,2'S,4aR,4bR,6aR,7R,8S,10aR,10bR,12aS)-7-(hydroxymethyl)-2'-[(1S)-2-hydroxy-1-methylethyl]-4a,4b,7,10a-tetramethylspiro[3,4,5,6,6a,8,9,10,10b,11,12,12a-dodecahydro-1H-chrysene-2,5'-tetrahydropyran]-1,8-diol; (1R,2S,2'S,4aR,4bR,6aR,7R,8S,10aR,10bR,12aS)-7-(hydroxymethyl)-2'-[(1S)-2-hydroxy-1-methyl-ethyl]-4a,4b,7,10a-tetramethyl-spiro[3,4,5,6,6a,8,9,10,10b,11,12,12a-dodecahydro-1H-chrysene-2,5'-tetrahydropyran]-1,8-diol |
|
492.82 |
|
TCMBANKIN036912 |
Neferine |
Nef; 4-[(6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-1-yl)methyl]-2-[[6-methoxy-1-[(4-methoxyphenyl)methyl]-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]oxy]phenol; Neferine; 12'-O-Methylliensinine; AC1L9HBD; CHEMBL1986816; 4-[(6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl]-2-({6-methoxy-1-[(4-methoxyphenyl)methyl]-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl}oxy)phenol; NSC708929; NCI60_038489; NSC-708929; CTK7A3596 |
C40H47NO6 |
638 |
c1(OC([H])([H])[H])c([H])c(C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[H])[C@]2(C([H])([H])[H])C([H])([H])c3c([H])c([H])c(OC([H])([H])[H])c([H])c3[H])c2c([H])c1Oc4c(O[H])c([H])c([H])c(C([H])([H])[C@]
5([H])c(c([H])c(OC([H])([H])[H])c(OC([H])([H])[H])c6[H])c6C([H])([H])C([H])([H])N5C([H])([H])[H])c4[H] |
TCMBANKIN036943 |
arbutin |
AC1OOCP4; (2R,3S,4R,5R,6S)-2-(hydroxymethyl)-6-(4-hydroxyphenoxy)oxane-3,4,5-triol; Arbutin; arbutin ; ericolin; ZINC5239485 |
C12H16O7 |
272.251 |
c1([H])c(O[H])c([H])c([H])c(O[C@]2([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]2([H])O[H])c1[H] |
TCMBANKIN039331 |
Syrionylglycerol-beta-syringaresinol |
syrionylglycerol-beta-syringaresinol |
C45H60O23 |
969.05 |
[C@]1([H])(O[H])[C@@]([H])(O[H])[C@]([H])(C([H])([H])O[H])O[C@]([H])(Oc2c(OC([H])([H])[H])c([H])c([C@]3([H])[C@@]([H])(C([H])([H])O[C@@]4([H])c5c([H])c(OC([H])([H])[H])c(O[C@]([H])([C@@]([H])(O[H])c6c
([H])c(OC([H])([H])[H])c(O[C@@]7([H])O[C@@]([H])(C([H])([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]7([H])O[H])c(OC([H])([H])[H])c6[H])C([H])([H])O[H])c(OC([H])([H])[H])c5[H])[C@]4([H])C([H])([H])O3)c
([H])c2OC([H])([H])[H])[C@@]1([H])O[H] |
TCMBANKIN042789 |
Apigenin-4'-O-β-D-xylofuranosyl(1→4)-O-β-D-glucopyranoside |
|
|
|
|
TCMBANKIN047018 |
Hosenkol A |
|
|
492.7 g/mol |
|
TCMBANKIN047181 |
Isoliensinine |
7-Isoquinolinol, 1,2,3,4-tetrahydro-1-((4-hydroxy-3-((1,2,3,4-tetrahydro-6-methoxy-1-((4-methoxyphenyl)methyl)-2-methyl-7-isoquinolinyl)oxy)phenyl)methyl)-6-methoxy-2-methyl-, (R-(R*,R*))-; 1-{[4-hydroxy-3-({6-methoxy-1-[(4-methoxyphenyl)methyl]-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl}oxy)phenyl]methyl}-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-ol; (1R)-1-[4-hydroxy-3-[[(1R)-6-methoxy-1-(4-methoxybenzyl)-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]oxy]benzyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol; Isoliensinine; Isoliensinin; 6817-41-0; (1R)-1-[[4-hydroxy-3-[[(1R)-6-methoxy-1-[(4-methoxyphenyl)methyl]-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]oxy]phenyl]methyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol; 7-Isoquinolinol, 1,2,3,4-tetrahydro-1-[[4-hydroxy-3-[[(1R)-1,2,3,4-tetrahydro-6-methoxy-1-[(4-methoxyphenyl)methyl]-2-methyl-7-isoquinolinyl]oxy]phenyl]methyl]-6-methoxy-2-methyl-, (1R)-; AIDS-226951; AIDS226951 |
C39H45NO6 |
624 |
c1(OC([H])([H])[H])c([H])c(C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[H])[C@]2(C([H])([H])[H])C([H])([H])c3c([H])c([H])c(OC([H])([H])[H])c([H])c3[H])c2c([H])c1Oc4c(O[H])c([H])c([H])c(C([H])([H])[C@]
5([H])c(c([H])c(O[H])c(OC([H])([H])[H])c6[H])c6C([H])([H])C([H])([H])N5C([H])([H])[H])c4[H] |
TCMBANKIN058213 |
kaemferol;kampferol;kaempferol;campherol |
TNP00039; nchembio.2007.28-comp30; Kaempherol; 5-18-05-00251 (Beilstein Handbook Reference); Prestwick2_001098; CHEBI:28499; Prestwick1_001098; CAS-520-18-3; BRN 0304401; Flavone, 3,4',5,7-tetrahydroxy-; ST030560; MEGxp0_001283; 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-5,7,4'-Trihydroxyflavonol; C.I. 75640; Swartziol; K0133_SIGMA; kaempferol oxoanion; NCGC00016480-01; 60010_FLUKA; EINECS 208-287-6; Pelargidenon; Nimbecetin; 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-4-chromenone; NSC 407289; 3,4',5,7-Tetrahydroxyflavone; HSCI1_000027; Pelargidenolon 1497; NSC407289; Robigenin; C05903; CPD1F-90; Kampferol; NSC 656277; Prestwick0_001098; 3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromen-4-one; Populnetin; Kampcetin; Prestwick3_001098; AIDS-001404; ZINC00137345; kaempferol ; 5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-olate; 3,4′,5,7-Tetrahydroxyflavone; Rhamnolutein; NCGC00016480-02; ACon1_001867; NSC656277; 3,4′,5,7-Tetrahydroxyflavone; BSPBio_001176; SPBio_003058; Oprea1_650954; 5,7,4'-Trihydroxyflavonol; 4H-1-Benzopyran-4-one,3,5,7-trihydroxy-2-(4-hydroxyphenyl)-5,7,4'-Trihydroxyflavonol; 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)- (9CI); Campherol; 520-18-3; 3,5,7-TRIHYDROXY-2-(4-HYDROXYPHENYL)-4H-CHROMEN-4-ONE; S00111; Trifolitin; Kampherol; AI3-36096; 3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromone; Indigo yellow; Pelargidenolon; AIDS001404; nchembio718-comp14; NCGC00091036-01; Flavone, 3,4',5,7-tetrahydroxy- (7CI,8CI); CHEBI:58573; Kaemferol; Kempferol; BPBio1_001294; 3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; Rhamnolutin; 3,5,7-triOH-Flavone; KMP; CCRIS 41; 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)- |
C15H10O6 |
286.24 g/mol |
C1=CC(=CC=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O |
TCMBANKIN058215 |
kaempferol-3-o-beta-d-glucoside |
kaempferol-3-O-β-D-glucopyranoside;Kaempferol-3-glucoside;astragalin;Kaempferol-3-o- glucoside;kaempferol 3-glucoside;Kaempferol 3-O-glucoside;kaempferol-3-o-glucoside;5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl beta-D-glucopyranoside; Kaempferol-3-O-.beta.-D-glucopyranoside; Kaempferol-3-beta-glucopyranoside; 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one; NCGC00163580-01; 4H-1-Benzopyran-4-one, 3-(beta-D-glucopyranosyloxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-; Astragaline; 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-chromen-4-one; Kaempferol-3-D-glucoside; 3-(beta-D-glucopyranosyloxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one; MEGxp0_000168; Kaempferol-3-beta-monoglucoside; Kaempferol-3-O-glucoside; 3,4',5,7-Tetrahydroxyflavone-3-glucoside; 480-10-4; ACon1_001224; SCHEMBL23898; 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-chromone; AIDS-051935; AIDS051935; CHEBI:30200; LMPK12111725; Kaempferol 3-O-beta-D-glucopyranoside; C12249; Astragalin; Kaempferol 3-O-glucoside; Kaempferol 3-glucoside; 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one; Kaempferol 3-O-beta-D-glucoside; 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-4-chromenone;kaempferol-3-β-D-glucopyranoside;Kaempferol-3-O-β-D- glucopyranoside; kaempferol-3-o-beta-d-glucopyranoside;kaempferol-3-O-β-D-glucoside; Kaempferol-3-o-β-D- glucoside; Kaempferol- 3-O-β-D-glucoside |
C21H20O11 |
448.38 |
C1=CC(=CC=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)O)O |
TCMBANKIN058591 |
Deoxypeganin |
Spectrum3_001158; BSPBio_002715; Spectrum5_000927; 1,2,3,9-Tetrahydro-pyrrolo[2,1-b]quinazoline; KBioGR_002479; 3-Deoxyvasicine; SPBio_001620; C10656; SDCCGMLS-0066767.P001; KBio3_002215; Deoxypeganine; 1,2,3,9-tetrahydropyrrolo[2,1-b]quinazoline; Desoxypeganine; 3-Deoxypeganine; Spectrum4_001977; Spectrum2_001690; BAS 00867603; ZINC00265524; Pyrrolo(2,1-b)quinazoline, 1,2,3,9-tetrahydro-; BB_NC-0767;AB00830873-05; MCULE-1061961665; Spectrum5_000927; 1,2,3,9-Tetrahydro-pyrrolo[2,1-b]quinazoline; ZX-AN036960; Desoxypeganine, HF Arzneimittelforschung; STOCK1N-10458; BBL010599; DTXSID40197807; Deoxypeganin; BRD-K13819402-003-02-9; KBioGR_002479; 3-Deoxyvasicine; ALBB-021365; SPBio_001620; 4,5-dihydropyrrolidino[2,1-b]quinazoline; SCHEMBL3387188; C10656; ST092796; AB00830873-04; SDCCGMLS-0066767.P001; AC1L9DLE; STK801663; HMS1672N18; SR-01000783332; KBio3_002215; Deoxypeganine; BDBM50289102; 61939-05-7 (hydrochloride); 1,2,3,9-tetrahydropyrrolo[2,1-b]quinazoline; D0T5AW; FCH834788; EN300-186641; ZINC265524; pyrrolo[2,1-b]quinazoline, 1,2,3,9-tetrahydro-, hydrochloride; Desoxypeganine; 3-Deoxypeganine; AKOS000591523; Spectrum4_001977; SR-01000783332-4; Spectrum2_001690; CHEBI:4428; BAS 00867603; 495-59-0; CHEMBL355821; Alcoholism therapy, HF Arzneimittelforschung; Pyrrolo(2,1-b)quinazoline, 1,2,3,9-tetrahydro-; MolPort-001-949-689;deoxypeganine |
C11H12N2 |
172.23 g/mol |
C1CC2=NC3=CC=CC=C3CN2C1 |
TCMBANKIN058638 |
higenamine |
UNII-6016M93W29; CHEBI:27751; (R)-Norcoclaurine; 6,7-Dihydroxy-(1R)-[(4-hydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline; 6,7-Isoquinolinediol, 1,2,3,4-tetrahydro-1-((4-hydroxyphenyl)methyl)-, (1R)-; (1R)-1-[(4-hydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol; 6016M93W29; SCHEMBL5898913; AX8328517; DTXSID90331552; (+)-HIGENAMINE; UNII-TBV5O16GAP component WZRCQWQRFZITDX-CQSZACIVSA-N; CHEMBL501778; 6,7-Isoquinolinediol, 1,2,3,4-tetrahydro-1-((4-hydroxyphenyl)methyl)-, (R)-; C06347; (R)-(+)-Higenamine; (+)-Demethylcoclaurine; 106032-53-5; BDBM50242856; AC1L9ACA; (1R)-1-(4-hydroxybenzyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diol; AK00743742; (R)-1-(4-Hydroxybenzyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diol; Higenamine, (+)-; ZINC896041; demethylcoclaurine; demetahyl coclaurine |
C16H17NO3 |
271.31 g/mol |
C1CNC(C2=CC(=C(C=C21)O)O)CC3=CC=C(C=C3)O |
TCMBANKIN058641 |
(-)-anonaine |
C09339; 3,5-DIOXA-11-AZAPENTACYCLO[10.7.1.0(2),?.0?,(2)?.0(1)?,(1)?]ICOSA-1(20),2(6),7,14,16,18-HEXAENE; 1862-41-5; SCHEMBL15800852; 3,5-dioxa-11-azapentacyclo[10.7.1.0;{2,6}.0;{8,20}.0;{14,19}]icosa-1(20),2(6),7,14(19),15,17-hexaene; 1,2-Methylenedioxynoraporphine; Anonaine; J3.604.525F; Anonain; ACon1_001472; NCGC00180471-01; AC1MR46Q; (-)-Annonaine; 5H-Benzo(g)-1,3-benzodioxolo(6,5,4-de)quinoline, 6,7,7a,7-tetrahydro-, (R)-; (+)-Anonaine;anonaine |
C17H15NO2 |
265.31 g/mol |
C1CNC2CC3=CC=CC=C3C4=C2C1=CC5=C4OCO5 |
TCMBANKIN059614 |
Amyrin |
|
C30H50O |
426.72 |
CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1)C)C)C |
TCMBANKIN059736 |
pyrolin |
|
C7H8O2 |
124.14 g/mol |
CC1=C(C=CC(=C1)O)O |
TCMBANKIN059940 |
Chimaphylin |
|
C12H10O2 |
186.21 |
CC1=CC2=C(C=C1)C(=O)C=C(C2=O)C |
TCMBANKIN060079 |
14-deoxy-11-oxoandrographolide |
|
C20H28O5 |
348.4 g/mol |
CC12CCC(C(C1CCC(=C)C2C(=O)CC3=CC(=O)OC3)(C)CO)O |
TCMBANKIN060161 |
afzelin |
|
C21H20O10 |
432.4 g/mol |
CC1C(C(C(C(O1)OC2=C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC=C(C=C4)O)O)O)O |
TCMBANKIN060679 |
stigmasterol |
|
C29H48O |
412.7 g/mol |
CCC(C=CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C |
TCMBANKIN060705 |
methyl linoleate |
|
C19H34O2 |
294.47 |
CCC=CCC=CCC=CCCCCCCCC(=O)OC |
TCMBANKIN060925 |
Methyl octylate |
|
C9H18O2 |
158.24 g/mol |
CCCCCCCC(=O)OC |
TCMBANKIN061030 |
Methyl myristate |
|
C15H30O2 |
242.4 g/mol |
CCCCCCCCCCCCCC(=O)OC |
TCMBANKIN061036 |
methyl pentadecanoate |
|
C16H32O2 |
256.42 |
CCCCCCCCCCCCCC(C)C(=O)O |
TCMBANKIN061058 |
n-hexadecane |
|
C16H34 |
226.44 g/mol |
CCCCCCCCCCCCCCCC |
TCMBANKIN061071 |
Ethylpalmitate |
|
C18H36O2 |
284.5 g/mol |
CCCCCCCCCCCCCCCC(=O)OCC |
TCMBANKIN061090 |
n-octadecane;Oktadekan;octadecane |
|
C18H38 |
254.49g/mol |
CCCCCCCCCCCCCCCCCC |
TCMBANKIN061093 |
ethyloctadecanoate |
|
C20H40O2 |
312.5 g/mol |
CCCCCCCCCCCCCCCCCC(=O)OCC |
TCMBANKIN061113 |
methyl henicosanoate |
|
C22H44O2 |
340.58 |
CCCCCCCCCCCCCCCCCCCCC(=O)OC |
TCMBANKIN061119 |
docosanoic acid,methyl ester |
|
C23H46O2 |
354.61 g/mol |
CCCCCCCCCCCCCCCCCCCCCC(=O)OC |
TCMBANKIN061327 |
liensinine |
2586-96-1; Lien; AIDS226949; Phenol, 4-[[(1R)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolinyl]methyl]-2-[[(1R)-1,2,3,4-tetrahydro-1-[(4-hydroxyphenyl)methyl]-6-methoxy-2-methyl-7-isoquinolinyl]oxy]-; Liensinine; 4-[[(1R)-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-1-yl]methyl]-2-[[(1R)-1-(4-hydroxybenzyl)-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]oxy]phenol; 4-[[(1R)-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-1-yl]methyl]-2-[[(1R)-1-[(4-hydroxyphenyl)methyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]oxy]phenol; Phenol, 4-((1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolinyl)methyl)-2-((1,2,3,4-tetrahydro-1-((4-hydroxyphenyl)methyl)-6-methoxy-2-methyl-7-isoquinolinyl)oxy)-, (R-(R*,R*))-; 4-[(6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl]-2-({1-[(4-hydroxyphenyl)methyl]-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl}oxy)phenol; AIDS-226949 |
C37H42N2O6 |
610.74 |
CN1CCC2=CC(=C(C=C2C1CC3=CC=C(C=C3)O)OC4=C(C=CC(=C4)CC5C6=CC(=C(C=C6CCN5C)OC)OC)O)OC |
TCMBANKIN061425 |
Methyl azelate |
NSC 59040; Dimethyl nonanedioate; 1732-10-1; Azelaic acid, dimethyl ester (8CI); Azelaic acid dimethyl ester; EINECS 217-060-0; 171026_ALDRICH; AI3-06080; Dimethyl azelate; ZINC01689486; Azelaic acid, dimethyl ester; 141850-72-8; NSC59040; nonanedioic acid dimethyl ester; Nonanedioic acid, dimethyl ester; DSSTox_GSID_44807; NSC 59040; X6034; Nonadioic acid, dimethyl ester; AN-20705; MCULE-3415352484; MFCD00025898; AS-19256; AJ-29983; Nonanedioic Acid Dimethyl Ester; FT-0622519; I14-45046; DSSTox_RID_80490; CHEMBL3188858; ST24030377; AK112196; NSC59040; Dimethyl azelate, >=98.5% (GC); Nonandioic acid, dimethyl ester; Dimethyl azeleate; NCGC00256050-01; KB-251652; UNII-29185K7OEI; Tox21_301713; 1732-10-1; Azelaic acid dimethyl ester; AI3-06080; DB-023082; dimethylazelate; 141850-72-8; AKOS015913922; Nonanedioic acid, dimethyl ester; KS-000014JH; Emery 2914; Azelaic acid, dimethyl ester (8CI); 29185K7OEI; CAS-1732-10-1; EINECS 217-060-0; DRUKNYVQGHETPO-UHFFFAOYSA-N; ST50825660; Dimethyl azelate; Azelaic acid, dimethyl ester; Azelaic acid,dimethyl ester; SCHEMBL118000; MolPort-003-927-086; NSC-59040; Dimethyl azelaate #; AC1L269C; 1,9-dimethyl nonanedioate; C-11681; DTXSID1044807; DIMETHYL NONANEDIOATE; EC 217-060-0; Dimethyl azelate, technical grade, 80%; ACMC-209e65; ZINC1689486; ANW-22635; AX8125373; M112322; Nonanedioic acid, 1,9-dimethyl ester; dimethyl nonane-1,9-dioate; CC-26948; TC-111380; SBB060332; DSSTox_CID_24807; EBD2210782; CTK8B1001; Methyl azelate; dimethyl azelate |
C11H20O4 |
216.27 g/mol |
COC(=O)CCCCCCCC(=O)OC |
TCMBANKIN061745 |
syringic acid; Syryngic; 1,5-dimethoxy-3-hydroxybenzoicacid; 3,5-dimethoxy-4-hydroxybenzoic acid; Cedar acid |
I01-1212; syringicacid; 3,5-dimethoxy-4-oxidanyl-benzoate; CHEBI:132111; 4-hydroxy-3,5-dimethoxybenzoate; c1409; ZB006317; AKOS015888648; A824548; A829374; CJ-01507; AC1OC351; ST51051575; C10833; DivK1c_006581; KBio3_002814; 530-57-4; AI3-24376; 3,5-Dimethoxy-4-hydroxybenzyl acid; S6881_SIGMA; BSPBio_003312; InChI=1/C9H10O5/c1-13-6-3-5(9(11)12)4-7(14-2)8(6)10/h3-4,10H,1-2H3,(H,11,12; EINECS 208-486-8; Gallic acid 3,5-dimethyl ether; Syringic acid; NSC2129; Spectrum3_001866; 4-10-00-01995 (Beilstein Handbook Reference); 4-Hydroxy-3,5-dimethoxybenzoic acid; SpecPlus_000485; NSC 2129; 4-hydroxy-3,5-dimethoxy-benzoic acid; Spectrum5_000963; ST5214746; KBio1_001525; BRN 2115262; 3,5-Dimethoxy-4-hydroxybenzoic acid; Benzoic acid, 4-hydroxy-3,5-dimethoxy- |
C9H10O5 |
198.17 g/mol |
COC1=CC(=CC(=C1O)OC)C(=O)O |